Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-874,032
Closed -$47.4M 654
2014
Q4
$47.4M Hold
874,032
0.13% 152
2014
Q3
$49.4M Buy
874,032
+73,360
+9% +$4.12M 0.14% 138
2014
Q2
$44.2M Hold
800,672
0.13% 165
2014
Q1
$43.4M Sell
800,672
-668,205
-45% -$34.6M 0.14% 146
2013
Q4
$70.2M Sell
1,468,877
-177,007
-11% -$8.09M 0.18% 148
2013
Q3
$74.8M Buy
1,645,884
+126,074
+8% +$5.76M 0.21% 129
2013
Q2
$67.4M Buy
+1,519,810
New +$67.9M 0.21% 139

Other funds holding MRK

Sculptor Capital's MRK Position: Q3 2022 in Review

Sculptor Capital sold out of Merck (MRK) in Q3 2022, closing a stake of 90,277 shares — an estimated $8.23M sold.

Sculptor Capital first reported a position in MRK in Q4 2013 and held it in 8 quarters. The position peaked at $58.4M in Q1 2019. 2,989 funds tracked by Wall St. Rank hold MRK as of Q3 2022.

  • Sculptor Capital reported no remaining Merck position as of Q3 2022 after selling out during the quarter.
  • Sculptor Capital sold 90,277 Merck shares in Q3 2022, an estimated $8.23M.
  • Sculptor Capital first reported a position in Merck in Q4 2013 and held it in 8 quarters.
  • Sculptor Capital's Merck position peaked at $58.4M in Q1 2019.
  • 2,989 funds tracked by Wall St. Rank held Merck as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.